Form 4: Guardant Health Director Tariq Musa Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. common stock and restricted stock units on October 15, 2024.

Summary

  • On October 15, 2024, Tariq Musa, a director of Guardant Health, Inc., reported transactions involving the company's common stock and restricted stock units.
  • Musa acquired 250 shares of common stock through the vesting of restricted stock units at a price of $0.
  • Following these transactions, Musa directly owns 4,746 shares of common stock and 7,246 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It is a standard practice for directors and officers of publicly traded companies.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares.

Key Dates

DateDescription
March 6, 2023Date of grant for the restricted stock units that vest over a four-year period.
March 15, 2023First vesting date for 25% of the restricted stock units.
October 15, 2024Date of the reported stock transactions (acquisition of 250 common stock shares and disposal of 250 restricted stock units).
October 16, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.